Furosemide

Product NDC: 52584-102
11-digit product format: 525840102
Labeler code: 52584
Product ID: 52584-102_fefaacb9-3dd1-45ed-bed4-3f1361850a66
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Furosemide
Dosage form: INJECTION, SOLUTION
Route: INTRAMUSCULAR; INTRAVENOUS
Labeler: General Injectables & Vaccines, Inc
Application: NDA018667
Marketing category: NDA
Marketing start: 2010-08-01
Marketing end: 0000-00-00
Substance: FUROSEMIDE
Active strength: 10 mg/mL
Pharmacologic classes: Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC]
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	52584-102		I	Inactivated by FDA	2026-08-17
excluded package	package	52584-102	52584-102-02	D	Discontinued by firm	2026-08-17
excluded package	package	52584-102	52584-102-04	D	Discontinued by firm	2026-08-17
excluded package	package	52584-102	52584-102-10	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 54 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52584-102-10	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52584-102-04	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52584-102-02	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52584-102-10	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52584-102-04	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52584-102-02	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52584-102-10	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52584-102-04	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52584-102-02	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	52584-102-10	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	52584-102-04	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	52584-102-02	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	52584-102-10	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	52584-102-04	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	52584-102-02	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	52584-102-10	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	52584-102-04	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	52584-102-02	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	52584-102-10	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	52584-102-04	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	52584-102-02	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	52584-102-10	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	52584-102-04	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	52584-102-02	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	52584-102-10	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	52584-102-04	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	52584-102-02	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	52584-102-10	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	52584-102-04	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	52584-102-02	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	52584-102-10	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	52584-102-04	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	52584-102-02	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	52584-102-10	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	52584-102-04	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	52584-102-02	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N018667-001	FUROSEMIDE	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP		1982-05-28

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
N018667-001	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N018667-001	FUROSEMIDE	10MG/ML	INJECTABLE / INJECTION	AP	1982-05-28	`e64feba35796…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	N018667-001	AP	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N018667-001	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018667-001	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N018667-001	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018667-001	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018667-001	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018667-001	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018667-001	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N018667-001	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N018667-001	AP	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N018667-001	AP	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N018667-001	AP	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N018667-001	AP	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N018667-001	AP	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N018667-001	AP	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N018667-001	AP	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N018667-001	AP	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N018667-001	AP	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N018667-001	AP	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N018667-001	AP	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N018667-001	AP	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N018667-001	AP	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N018667-001	AP	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N018667-001	AP	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N018667-001	AP	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N018667-001	AP	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N018667-001	AP	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N018667-001	AP	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N018667-001	AP	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N018667-001	AP	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N018667-001	AP	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N018667-001	AP	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N018667-001	AP	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N018667-001	AP	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N018667-001	AP	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N018667-001	AP	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N018667-001	AP	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N018667-001	AP	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N018667-001	AP	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N018667-001	AP	1	`e64feba35796…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d80d3aff-3a63-4d7b-a2be-fd9388b04330	Product name	9	20250806
9061e89f-9c86-4196-b34b-886fc1673cc4	Product name	1	20140821

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
52584-102-02	2022-01-28	C162847	48780-1	d6a99b39-50a1-a426-e053-dadaa90af4c2	Furosemide Injection, USP (10 mg/mL) Fliptop Vial Ansyr™ Plastic Syringe Rx only
52584-102-04	2022-01-28	C162847	48780-1	d6a99b39-50a1-a426-e053-dadaa90af4c2	Furosemide Injection, USP (10 mg/mL) Fliptop Vial Ansyr™ Plastic Syringe Rx only
52584-102-10	2022-01-28	C162847	48780-1	d6a99b39-50a1-a426-e053-dadaa90af4c2	Furosemide Injection, USP (10 mg/mL) Fliptop Vial Ansyr™ Plastic Syringe Rx only

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
52584-102-02	Furosemide	1 in 1 BAG	INJECTION, SOLUTION	1	14
52584-102-02	Furosemide	2 mL in 1 VIAL, SINGLE-DOSE	INJECTION, SOLUTION	2	14
52584-102-04	Furosemide	1 in 1 BAG	INJECTION, SOLUTION	1	14
52584-102-04	Furosemide	4 mL in 1 VIAL, SINGLE-DOSE	INJECTION, SOLUTION	4	14
52584-102-10	Furosemide	1 in 1 BAG	INJECTION, SOLUTION	1	14
52584-102-10	Furosemide	10 mL in 1 VIAL, SINGLE-DOSE	INJECTION, SOLUTION	10	14

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version	Uploaded
Furosemide	ACTIVE INGREDIENT	7LXU5N7ZO5	FUROSEMIDE INJECTION, SOLUTION [GENERAL INJECTABLES & VACCINES, INC]	5
Furosemide	ACTIVE MOIETY	7LXU5N7ZO5	FUROSEMIDE INJECTION, SOLUTION [GENERAL INJECTABLES & VACCINES, INC]	5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
52584-102	FUROSEMIDE INJECTION, SOLUTION [GENERAL INJECTABLES & VACCINES, INC]	14	Legacy NDC, 6 package rows	20190904_869c9eeb-baae-4189-aa5e-0b4e1ee172d2.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Furosemide	FUROSEMIDE	Medical Purchasing Solutions, LLC	58cc1e38-6000-1489-e063-6394a90a5978	2026-08-11	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018667 application number: NDA018667
FUROSEMIDE	FUROSEMIDE	HF Acquisition Co LLC, DBA HealthFirst	75d5611a-f9e0-1841-e053-2991aa0af415	2026-06-23	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018667 application number: NDA018667
Furosemide	FUROSEMIDE	Cardinal Health 107, LLC	71b48f4d-9936-448c-9e3a-33f1182e1039	2026-05-15	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018667 application number: NDA018667
Furosemide	FUROSEMIDE	Hospira, Inc.	39fd32f2-6bb7-4a65-d298-e48d26bc80c7	2026-05-13	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018667 application number: NDA018667
FUROSEMIDE	FUROSEMIDE	Hospira, Inc.	aaced7a8-c3d7-4d66-8c07-aa407b8b3f35	2026-05-13	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018667 application number: NDA018667
Furosemide	FUROSEMIDE	Cardinal Health 107, LLC	8e0bac29-5a8b-4d4e-93b3-2e21eb3b0650	2026-05-06	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018667 application number: NDA018667
FUROSEMIDE	FUROSEMIDE	HF Acquisition Co LLC, DBA HealthFirst	75d68f19-424c-109e-e053-2991aa0ac857	2024-01-30	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018667 application number: NDA018667
FUROSEMIDE	FUROSEMIDE	HF Acquisition Co LLC, DBA HealthFirst	7b9af6a4-e1da-eb95-e053-2991aa0a031d	2024-01-22	Warnings, Adverse reactions	Exact identifier application applno (NDA): 018667 application number: NDA018667

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
7LXU5N7ZO5	FUROSEMIDE	54-31-9	FUROSEMIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1719286	furosemide 100 MG in 10 ML Injection	PSN	869c9eeb-baae-4189-aa5e-0b4e1ee172d2	14
1719290	furosemide 20 MG in 2 ML Injection	PSN	869c9eeb-baae-4189-aa5e-0b4e1ee172d2	14
1719291	furosemide 40 MG in 4 ML Injection	PSN	869c9eeb-baae-4189-aa5e-0b4e1ee172d2	14
1719286	10 ML furosemide 10 MG/ML Injection	SCD	869c9eeb-baae-4189-aa5e-0b4e1ee172d2	14
1719290	2 ML furosemide 10 MG/ML Injection	SCD	869c9eeb-baae-4189-aa5e-0b4e1ee172d2	14
1719291	4 ML furosemide 10 MG/ML Injection	SCD	869c9eeb-baae-4189-aa5e-0b4e1ee172d2	14
1719286	furosemide 100 MG per 10 ML Injection	SY	869c9eeb-baae-4189-aa5e-0b4e1ee172d2	14
1719290	furosemide 20 MG per 2 ML Injection	SY	869c9eeb-baae-4189-aa5e-0b4e1ee172d2	14
1719291	furosemide 40 MG per 4 ML Injection	SY	869c9eeb-baae-4189-aa5e-0b4e1ee172d2	14

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
52584-102-02	52584010202	1 in 1 BAG	Historical
52584-102-04	52584010204	1 in 1 BAG	Historical
52584-102-10	52584010210	1 in 1 BAG	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Furosemide Injection, USP (10 mg/mL) Fliptop Vial Ansyr™ Plastic Syringe Rx only	General Injectables & Vaccines, Inc	2019-09-03	HUMAN PRESCRIPTION DRUG LABEL	14